Recent literature indicated that GLP-1R agonist Ex4 appears highly promising in attenuating the rewarding and reinforcing effects of cocaine addiction (Hernandez and Schmidt, 2019; Zhu et al., 2021). The gene discussed is GLP1R; the disease is cocaine dependence.